Ekso Bionics to Report Third Quarter 2023 Financial Results on October 26, 2023
19 Octubre 2023 - 3:05PM
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an
industry leader in exoskeleton technology for medical and
industrial use, today announced that it will release financial and
business results for the third quarter 2023 after the close of
trading on Thursday, October 26, 2023. Management will host a
conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss
the financial results and recent business developments.
A live webcast of the event will be available in
the “Investors” section of the Company’s website at
www.eksobionics.com, or by clicking here. Investors interested in
listening to the conference call may do so by dialing 877-407-3036
for domestic callers or 201-378-4919 for international callers.
The webcast will be available on the Company’s
website for one month following the completion of the call.
About Ekso
Bionics® Ekso Bionics® is a leading
developer of exoskeleton solutions that amplify human potential by
supporting or enhancing strength, endurance and mobility across
medical and industrial applications. Founded in 2005, the Company
continues to build upon its industry-leading expertise to design
some of the most cutting-edge, innovative wearable robots available
on the market. Ekso Bionics is the only known exoskeleton company
to offer technologies that range from helping those with paralysis
to stand up and walk, to enhancing human capabilities on job sites
across the globe. The Company is headquartered in the San Francisco
Bay Area and is listed on the Nasdaq Capital Market under the
symbol “EKSO.” For more information, visit: www.eksobionics.com or
follow @EksoBionics on X, formerly Twitter.
Investor Contact: David Carey212-867-1768
investors@eksobionics.com
Ekso Bionics (NASDAQ:EKSO)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Ekso Bionics (NASDAQ:EKSO)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024